Kim Forest Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018
April 08, 2019 at 04:45 pm
Share
Kim Forest Enterprise Co., Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 231.782 million compared to TWD 264.275 million a year ago. Operating loss was TWD 38.042 million compared to operating Income of TWD 11.375 million a year ago. Net loss was TWD 30.720 million compared to net income of TWD 8.833 million a year ago. Basic loss per share was TWD 1.52 compared to basic earnings per share of TWD 0.49 a year ago.
KIM FOREST ENTERPRISE CO., LTD. is a Taiwan-based company mainly engaged in sale of biomedical products and provision of genetic testing and analysis services. The Company operates through two segments. The Biomedical Experiment Products segment is engaged in provision of laboratory equipment, reagents, supplies and equipment maintenance services. Main products include filter type microplate spectrophotometer, polymerase chain reaction (PCR) molecular biology experiment related equipment and reagents, equipment and reagents for separating cell, protein and nucleic acids, rapid DNA detection reagent and others. The Biotechnology and Genetic Testing segment is engaged in provision of whole genome sequencing (WGS) and whole exome sequencing(WES) tumor analysis services, RNA sequencing analysis, and new drug development system and check services.
KIM FOREST ENTERPRISE CO., LTD. 
